Summary of Classification and Labelling
Notified classification and labelling
General Information
211-141-4 |
Prednisolone 21-(3-sodium-sulphobenzoate) |
630-67-1 |
Notified classification and labelling according to CLP criteria
Repr. 2 |
H361
(oral)
(H361d: suspecte...)
|
H361
(H361d)
|
|
GHS08 Wng
|
|
|
|
|
2 |
|
View details
|
Repr. 2 |
H361
(H361d: suspecte...)
|
H361
(H361d)
|
STOT RE 2 |
H373
(other:unknown)
|
H373
|
Not Classified |
|
|
|
|
|
|
|
|
2 |
|
|
|
|
H302+H312+H332
|
|
GHS07 Wng
|
|
|
|
|
1 |
|
View details
|
|
|
H351
(Suspected of ca...)
|
|
|
H373
(May cause damag...)
|
Number of Aggregated Notifications: 3